StockWatchIndex Publishes Pressure BioSciences Research Report
Pressure BioSciences Research Report
A Technology Leader in an expanding Market

Los Angeles - July 14, 2106 - StockWatchIndex announced today that it has initiated coverage of Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) and has published the first  research report on PBI.

PBI Patented  Technology
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, including in the discovery of biomarkers with a worldwide market estimated to be $26 Billion. PBI’s products are based on the unique properties of both constant (static) and alternating (pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions  

Over 250 Systems Installed
We believe that the company is well positioned in a rapidly growing market with strong technological and economical advantages over the competition. PBI has already over 250 PCT systems installed worldwide and has  entered into a co-marketing agreement with SCIEX, the clear market leader in the mass spec field for proteomics with a commanding market share. Based on this agreement with SCIEX and the expectations expressed by the company, we anticipate double-digit growth in 2016 and rapid growth in the years to follow.
PBI Pressure Cycling Technology - A Game Changer
Donnload the SWI Research Report Here
 S tockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has been engaged by Small Cap Nation, an on-demand video news and information broadcasting platform and will be compensated in cash for the publication of the information herein . The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.